TROPHY-U-01: Sacituzumab Govitecan for Platinum-ineligible Metastatic UC
Daniel P. Petrylak, MD, a Professor of Medicine and Urology at the Yale School of Medicine, overviews the TROPHY-U-01 study for platinum-ineligible patients with metastatic urothelial carcinoma who have progressed on checkpoint inhibitor therapy.
670 Madison Ave.
Manalapan, NJ 07726
Contributors and Partners
Cancer Nursing Today
Urban Health Today
Blood Cancers Today
© 2023 Mashup Media, LLC. All rights reserved.